Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma
Clinical trial NCT01747876 · TERMINATED
Trial details
- NCT number
- NCT01747876
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-28
- Primary completion
- 2017-06-29
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.